Variant report
Variant | esv3436514 |
---|---|
Chromosome Location | chr2:50674348-50675546 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs202078678 | chr2:50674360-50674361 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs148036595 | chr2:50674395-50674396 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs538167871 | chr2:50674410-50674411 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs369263001 | chr2:50674455-50674456 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs556479704 | chr2:50674462-50674463 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs1915169 | chr2:50674531-50674532 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs111369930 | chr2:50674569-50674570 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs13014251 | chr2:50674573-50674574 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs573328120 | chr2:50674581-50674582 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs35878890 | chr2:50674630-50674631 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs57041108 | chr2:50674642-50674643 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs540370749 | chr2:50674661-50674662 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs562143394 | chr2:50674667-50674668 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs529258918 | chr2:50674788-50674789 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs115273212 | chr2:50674837-50674838 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs200781049 | chr2:50674860-50674861 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs34330104 | chr2:50674870-50674871 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs370066758 | chr2:50674876-50674877 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs34602832 | chr2:50674877-50674878 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs4276063 | chr2:50674878-50674879 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs200200738 | chr2:50674879-50674880 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs70948710 | chr2:50674898-50674899 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs202098569 | chr2:50674936-50674937 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs562812741 | chr2:50674939-50674940 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs533350881 | chr2:50674977-50674978 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs551516600 | chr2:50675023-50675024 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs566939369 | chr2:50675061-50675062 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs533934382 | chr2:50675076-50675077 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs548781797 | chr2:50675093-50675094 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs573624885 | chr2:50675101-50675102 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs139993365 | chr2:50675108-50675109 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs115559191 | chr2:50675110-50675111 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs556501892 | chr2:50675116-50675117 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs571526974 | chr2:50675130-50675131 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs538925764 | chr2:50675182-50675183 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs554056665 | chr2:50675199-50675200 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs572128037 | chr2:50675221-50675222 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs540757644 | chr2:50675228-50675229 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs114390585 | chr2:50675243-50675244 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs574002972 | chr2:50675272-50675273 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs544151959 | chr2:50675282-50675283 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs542343646 | chr2:50675305-50675306 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs560363324 | chr2:50675308-50675309 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs72878310 | chr2:50675324-50675325 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs533483891 | chr2:50675325-50675326 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs143468099 | chr2:50675355-50675356 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs373600564 | chr2:50675393-50675394 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs560765290 | chr2:50675439-50675440 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs527865543 | chr2:50675459-50675460 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs549076277 | chr2:50675475-50675476 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 17297452 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 20433910 | CNVD |
Autism | 21701786 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Schizophrenia | 20587603 | CNVD |
Schizophrenia | 20553308 | CNVD |
Autism | 22241247 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 18768390 | CNVD |
Mental retardation | 19521722 | CNVD |
Schizophrenia | 18990708 | CNVD |
Schizophrenia | 18940311 | CNVD |
Schizophrenia | 19348701 | CNVD |
Schizophrenia | 18945720 | CNVD |
Schizophrenia | 19571808 | CNVD |
Prostate cancer | 16573809 | CNVD |
Neuroticism | 17667963 | CNVD |
Schizophrenia | 19443537 | CNVD |
Schizophrenia | 19546859 | CNVD |
Autism | 17322880 | CNVD |
Lung cancer | 17086460 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Cognitive impairment | 21505072 | CNVD |
Psychiatric disorder | 19734545 | CNVD |
Autism | 20844286 | CNVD |
Schizophrenia | 20838587 | CNVD |
Schizophrenia | 20718829 | CNVD |
Autism | 19218893 | CNVD |
Autism | 22209245 | CNVD |
Neuropsychiatric disorder | 21827697 | CNVD |
Schizophrenia | 22118685 | CNVD |
Autism | 20663923 | CNVD |
Schizophrenia | 21285140 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21990379 | CNVD |
Schizophrenia | 22885689 | CNVD |
Autism | 20964600 | CNVD |
Schizophrenia | 19521646 | CNVD |
Attention deficit hyperactivity disorder | 22214315 | CNVD |
Chronic motor tic disorder | 22214315 | CNVD |
Schizophrenia | 22214315 | CNVD |
Mental retardation | 19896112 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Autism | 20531469 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:50671000-50675200 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr2:50671400-50675600 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
3 | chr2:50672400-50675200 | Weak transcription | Stomach Mucosa | stomach |
4 | chr2:50672400-50675400 | Weak transcription | Brain Germinal Matrix | brain |
5 | chr2:50673000-50675400 | Weak transcription | Hela-S3 | cervix |
6 | chr2:50673800-50684200 | Weak transcription | Fetal Brain Male | brain |
7 | chr2:50675200-50675600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
8 | chr2:50675200-50676600 | Enhancers | Fetal Brain Female | brain |
9 | chr2:50675400-50675600 | Enhancers | Stomach Mucosa | stomach |
10 | chr2:50675400-50676000 | Flanking Active TSS | Brain Germinal Matrix | brain |
11 | chr2:50675400-50677000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
12 | chr2:50675400-50677200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
13 | chr2:50675400-50677400 | Enhancers | Hela-S3 | cervix |